012330:KRXHyundai Mobis Co., Ltd Analysis
Data as of 2026-03-11 - not real-time
₩433,000.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hyundai Mobis is trading above its DCF‑derived fair value, yet the stock benefits from a low beta and a modest dividend yield that is supported by a low payout ratio and ample cash reserves. Technical signals are mixed: the 20‑day SMA sits above the current price, the MACD is in a bearish configuration, while the 30‑day volatility is elevated and the RSI hovers near the neutral zone, suggesting short‑term price pressure. Fundamentally, the company shows solid operating cash flow, a strong dividend policy, and a strategic push into cybersecurity and next‑generation display technologies, which could fuel medium‑ to long‑term growth.
Given the blend of cyclical exposure, global geographic footprint, and ongoing innovation initiatives, the stock appears fairly positioned for a hold in the near term, with upside potential if the market re‑prices the growth narrative and the valuation gap narrows.
Given the blend of cyclical exposure, global geographic footprint, and ongoing innovation initiatives, the stock appears fairly positioned for a hold in the near term, with upside potential if the market re‑prices the growth narrative and the valuation gap narrows.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating potential downside pressure
- Current price below 20‑day SMA suggesting limited upside
- High short‑term volatility increasing risk
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash generation and low dividend payout supporting sustainability
- Strategic alliances in display and cybersecurity enhancing growth prospects
- Moderate valuation gap that may close as earnings improve
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Positioning in EV, autonomous driving and electrification markets
- Continued dividend reliability with ample cash buffers
- Global diversification reducing reliance on any single region
Key Metrics & Analysis
Financial Health
Revenue Growth7.40%
Profit Margin6.90%
P/E Ratio8.0
ROE9.16%
ROA3.23%
Debt/Equity8.22
Op. Cash Flow₩4630.0B
Free Cash Flow₩1202.7B
Technical Analysis
TrendBullish
RSI48.4
Support₩387,500.00
Resistance₩531,000.00
MA 20₩446,550.00
MA 50₩431,420.00
MA 200₩333,277.50
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair Value₩343,771.08
Target Price₩536,966.70
Upside/Downside24.01%
GradeOvervalued
TypeBlend
Dividend Yield1.54%
Risk Assessment
Beta0.44
Volatility80.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.